Finally, a recent clinical study found that individuals with higher adiponectin levels tend to perform better in a delayed word recall test, supporting the notion that adiponectin is a protective factor against cognitive decline and represents a promising therapeutic strategy in cognitive disorders (Cezaretto et al., 2018). This evidence concerns the gene ADIPOQ and cognitive disorder.